Home › Funds › Jones Hill Capital LP › BCAX

Jones Hill Capital LP position in BCAX

BICARA THERAPEUTICS INC · Health Care

Jones Hill Capital LP reported holding 1,064,233 shares of BCAX (BICARA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$19.8M, representing 3.36% of its reported portfolio and ranking #12 among its reported holdings. Jones Hill Capital LP has disclosed BCAX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)1.06M sh
Reported value held$19.81M
Portfolio Weight3.36%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Jones Hill Capital LP's BCAX position evolved

Jones Hill Capital LP first disclosed a stake in BCAX in Q1 2026 at 1,260,136 shares (US$25.1M). The position peaked in Q2 2026 at 892,621 shares, worth US$26.5M. Across 3 filings, Jones Hill Capital LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,064,233 shares valued at US$19.8M — an increase of 171,612 shares quarter over quarter.. Notable position changes include a 29% trim in Q2 2026 (shares fell 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.26M $25.06M New
Q2 2026 892.62K $26.50M Reduce
Q3 2026 1.06M $19.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 50 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Vestal Point Capital, LP (US$155.9M), Deep Track Capital, LP (US$121.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has Jones Hill Capital LP held BCAX?

Jones Hill Capital LP has disclosed BCAX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Jones Hill Capital LP's current position in BCAX?

As of Q3 2026, Jones Hill Capital LP holds 1.06M shares of BCAX (BICARA THERAPEUTICS INC), valued at $19.81M, representing 3.36% of its reported portfolio and ranking #12.

Has Jones Hill Capital LP been buying or selling BCAX?

In the latest 13F filing (Q3 2026), Jones Hill Capital LP increased its position in BCAX. The position peaked in Q2 2026 at 892.62K shares.

Which other funds hold BCAX?

Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Deep Track Capital, LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.